373 related articles for article (PubMed ID: 32453863)
1. COVID-19 and ABO blood group: another viewpoint.
Gérard C; Maggipinto G; Minon JM
Br J Haematol; 2020 Jul; 190(2):e93-e94. PubMed ID: 32453863
[No Abstract] [Full Text] [Related]
2. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.
O'Sullivan JM; Ward S; Fogarty H; O'Donnell JS
Br J Haematol; 2020 Jul; 190(1):27-28. PubMed ID: 32420611
[No Abstract] [Full Text] [Related]
3. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?
Rongioletti F
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e581-e582. PubMed ID: 32526085
[No Abstract] [Full Text] [Related]
4. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.
Wu Y; Feng Z; Li P; Yu Q
Clin Chim Acta; 2020 Oct; 509():220-223. PubMed ID: 32562665
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
Al-Tawfiq JA
Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
[No Abstract] [Full Text] [Related]
6. COVID-19 and ABO blood groups.
Dzik S; Eliason K; Morris EB; Kaufman RM; North CM
Transfusion; 2020 Aug; 60(8):1883-1884. PubMed ID: 32562280
[No Abstract] [Full Text] [Related]
7. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Bölke E; Matuschek C; Fischer JC
N Engl J Med; 2020 Oct; 383(17):1694-1695. PubMed ID: 32966710
[No Abstract] [Full Text] [Related]
8. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
French MA; Moodley Y
Respirology; 2020 Jul; 25(7):680-682. PubMed ID: 32436320
[No Abstract] [Full Text] [Related]
9. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
Yang OO; Ibarrondo FJ
N Engl J Med; 2020 Oct; 383(17):1697-1698. PubMed ID: 32966713
[No Abstract] [Full Text] [Related]
10. A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
Liu L; Quan J; Lv J; Long S; Hu W; Zhuge H; Zhou Z; Zhao D
J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283138
[No Abstract] [Full Text] [Related]
11. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Kutsuna S; Asai Y; Matsunaga A
N Engl J Med; 2020 Oct; 383(17):1695-1696. PubMed ID: 32966712
[No Abstract] [Full Text] [Related]
12. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Terpos E; Mentis A; Dimopoulos MA
N Engl J Med; 2020 Oct; 383(17):1695. PubMed ID: 32966711
[No Abstract] [Full Text] [Related]
13. Going back in time for an antibody to fight COVID-19.
Whittaker GR; Daniel S
Nature; 2020 Jul; 583(7815):203-204. PubMed ID: 32623442
[No Abstract] [Full Text] [Related]
14. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.
Li J; Wang X; Chen J; Cai Y; Deng A; Yang M
Br J Haematol; 2020 Jul; 190(1):24-27. PubMed ID: 32379894
[No Abstract] [Full Text] [Related]
15. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan.
Fan Q; Zhang W; Li B; Li DJ; Zhang J; Zhao F
Front Cell Infect Microbiol; 2020; 10():404. PubMed ID: 32793517
[No Abstract] [Full Text] [Related]
16. Challenges and issues of SARS-CoV-2 pool testing.
Eberhardt JN; Breuckmann NP; Eberhardt CS
Lancet Infect Dis; 2020 Nov; 20(11):1233-1234. PubMed ID: 32679088
[No Abstract] [Full Text] [Related]
17. Challenges and issues of SARS-CoV-2 pool testing.
Mishra B; Behera B; Mohanty M; Ravindra A; Ranjan J
Lancet Infect Dis; 2020 Nov; 20(11):1233. PubMed ID: 32679083
[No Abstract] [Full Text] [Related]
18. Challenges and issues of SARS-CoV-2 pool testing.
Lee J; Kim SY; Sung H; Lee SW; Lee H; Roh KH; Yoo CK; Hong KH
Lancet Infect Dis; 2020 Nov; 20(11):1232-1233. PubMed ID: 32679080
[No Abstract] [Full Text] [Related]
19. Why Does SARS-CoV-2 Invade the Gastrointestinal Epithelium?
Uno Y
Gastroenterology; 2020 Oct; 159(4):1622-1623. PubMed ID: 32283099
[No Abstract] [Full Text] [Related]
20. COVID-19 and cardiovascular disorder.
Mungmungpuntipantip R; Wiwanitkit V
Minerva Cardioangiol; 2020 Jun; 68(3):277. PubMed ID: 32319272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
